Stay updated with breaking news from Weiler Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Continued global efforts to incorporate BFS in the safe and efficient delivery of life-saving vaccines are proof the technology serves as a valuable...
05/27/21 Pharmaceutical Online Newsletter
04.27.21 -- Life Sciences Investment Outlook: Deal-Making Gets Creative Catching up to the paradigm shift in optimizing, scaling-up, and manufacturing plasmids is crucial for clinical to commercial program success for gene therapies and vaccines. With an increased demand for plasmids for targeted gene therapeutic delivery, partnering with a CDMO equipped with the capacity, expertise, and equipment for plasmid DNA production is critical to ensuring a stable therapeutic supply. Join Aji Bio-Pharma to learn about methodologies to ensure effective productio...
04.20.21 -- FDA Inspections: Are Changes On The Horizon? To get the most out of data, you must ensure they are findable, accessible, interoperable, and reusable — F.A.I.R. for short. Organizations simply don’t have the infrastructure in place to be able to capture data with context and then store them so that they can be searched and accessed with ease. We’ll explore how you can change that using the F.A.I.R. principles, which have been recognized as standards to enable for that potential to be realized. Featured Editorial By Kalah Auchincloss, Gr...
03.09.21 -- Incorporating Excipients Into QbD Studies For Drug Development -- An Introduction Orphan drugs are notorious for their high costs and risk factors, which are attributed to smaller patient pools and higher development and launch costs. Attend this webinar to learn more about key trends that are causing the rise of orphan drug indications, fast-tracking early development phases that will lead to commercial success, and more! By Brian Carlin (DFE Pharma), Chris Moreton (FinnBrit Consulting), Dave Schoneker (Black Diamond Consulting), K...